Latest filing published 27 Dec 2018 for Novelion Therapeutics Inc., €53k.
Kevin Kotler discloses dealings in Novelion Therapeutics Inc. to SEDI. Between 16 December 2016 and 26 December 2018, the trades on record add up to 4 filings.
Every open-market trade on record is a sale: 3 sales worth €53k. 2018 to date brings no purchases and 3 sales.
The newest entry dates from 27 December 2018: an open-market sale of €53k, in Novelion Therapeutics Inc. Typically, a trade is published a median of 2 days after it takes place. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations